Acro Biomedical (ACBM) Cash from Financing Activities (2017 - 2025)
Acro Biomedical's quarterly Cash from Financing Activities came in at $25152.0 in Q4 2025, up 144.43% year-on-year from $10290.0 in Q4 2024, and down 57.16% quarter-over-quarter from $58707.0 in Q3 2025.
Acro Biomedical has reported Cash from Financing Activities for 9 years, with the latest figure at $25152.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Financing Activities rose 144.43% year-over-year to $25152.0; the trailing twelve-month figure through Dec 2025 stood at $199924.0 (up 443.39% YoY), and the FY2025 full-year result was $199924.0, up 443.39% from the prior year.
- Cash from Financing Activities for Q4 2025 stood at $25152.0, down from $58707.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $93759.0 in Q2 2025, with the low at -$241635.0 in Q2 2021.
- Average Cash from Financing Activities over 5 years is $4128.0, with a median of $6607.0 recorded in 2024.
- Year-over-year, Cash from Financing Activities sank 492.42% in 2021 and surged 36811.11% in 2024.
- Tracing ACBM's Cash from Financing Activities over 5 years: stood at $1091.0 in 2021, then plunged by 78.74% to $232.0 in 2022, then surged by 4088.79% to $9718.0 in 2023, then rose by 5.89% to $10290.0 in 2024, then surged by 144.43% to $25152.0 in 2025.
- The last three Cash from Financing Activities figures came in at $25152.0 (Q4 2025), $58707.0 (Q3 2025), and $93759.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | - |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | -250,000.00 |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | - |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | 500,000.00 |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | -17.38 Mn |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | - |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | - |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | - |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | - |
| 10 | Acro Biomedical | - | - | - | 25,152.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 25,152.00 |
| Dec 31, 2025 | 25,152.00 |
| Sep 30, 2025 | 58,707.00 |
| Sep 30, 2025 | 58,707.00 |
| Jun 30, 2025 | 93,759.00 |
| Jun 30, 2025 | 93,759.00 |
| Mar 31, 2025 | 22,306.00 |
| Mar 31, 2025 | 22,306.00 |
| Dec 31, 2024 | 10,290.00 |
| Dec 31, 2024 | 10,290.00 |
| Sep 30, 2024 | 6,110.00 |
| Sep 30, 2024 | 6,110.00 |
| Jun 30, 2024 | 7,104.00 |
| Jun 30, 2024 | 7,104.00 |
| Mar 31, 2024 | 13,288.00 |
| Mar 31, 2024 | 13,288.00 |
| Dec 31, 2023 | 9,718.00 |
| Dec 31, 2023 | 9,718.00 |
| Sep 30, 2023 | 108.00 |
| Sep 30, 2023 | 108.00 |
| Jun 30, 2023 | 108.00 |
| Jun 30, 2023 | 108.00 |
| Mar 31, 2023 | 36.00 |
| Mar 31, 2023 | 36.00 |
| Dec 31, 2022 | 232.00 |
| Dec 31, 2022 | 232.00 |
| Sep 30, 2022 | 57,349.00 |
| Sep 30, 2022 | 57,349.00 |
| Jun 30, 2022 | 216.00 |
| Jun 30, 2022 | 216.00 |
| Mar 31, 2022 | 288.00 |
| Mar 31, 2022 | 288.00 |
| Dec 31, 2021 | 1,091.00 |
| Dec 31, 2021 | 1,091.00 |
| Sep 30, 2021 | 3,718.00 |
| Sep 30, 2021 | 3,718.00 |
| Jun 30, 2021 | -241,635.00 |
| Jun 30, 2021 | -241,635.00 |
| Mar 31, 2021 | 14,616.00 |
| Mar 31, 2021 | 14,616.00 |
| Sep 30, 2020 | 64,376.00 |
| Sep 30, 2020 | 64,376.00 |
| Jun 30, 2020 | 61,576.00 |
| Jun 30, 2020 | 61,576.00 |
| Mar 31, 2020 | 35,739.00 |
| Mar 31, 2020 | 35,739.00 |
| Dec 31, 2019 | -35,489.00 |
| Dec 31, 2019 | -35,489.00 |
| Sep 30, 2019 | 58,502.00 |
| Sep 30, 2019 | 58,502.00 |
| Jun 30, 2019 | 100,135.00 |
| Jun 30, 2019 | 100,135.00 |
| Mar 31, 2019 | 15,140.00 |
| Mar 31, 2019 | 15,140.00 |
| Dec 31, 2018 | -137,870.00 |
| Dec 31, 2018 | -137,870.00 |
| Sep 30, 2018 | 700.00 |
| Sep 30, 2018 | 700.00 |
| Jun 30, 2018 | 45,142.00 |
| Jun 30, 2018 | 45,142.00 |
| Mar 31, 2018 | 53,923.00 |
| Mar 31, 2018 | 53,923.00 |
| Dec 31, 2017 | 4,992.00 |
| Dec 31, 2017 | 4,992.00 |
| Sep 30, 2017 | 452,985.00 |
| Sep 30, 2017 | 452,985.00 |
| Jun 30, 2017 | 17,554.00 |
| Jun 30, 2017 | 17,554.00 |